Showing results (341-350 of 491) with videos related to
Sort By:
Pageof 50
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Effects of beta3-integrin blockade (c7E3) on the response to angioplasty and intra-arterial stenting in atherosclerotic nonhuman primatesJ S Deitch, J K Williams, M R Adams, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2012
Adenovirus viremia and disease: comparison of T cell-depleted and conventional hematopoietic stem cell transplantation recipients from a single institutionYeon Joo Lee, Dick Chung, Kun Xiao, et al.British Journal of Clinical Pharmacology|June 22, 2011
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variantsRonan P Kelly, Sandra L Close, Nagy A Farid, et al.Clinical Trials (London, England)|July 27, 2017
Successful utilization of an electronic pain diary in a multinational phase 3 interventional study of pediatric sickle cell anemiaLori E Heath, Matthew M Heeney, Carolyn C Hoppe, et al.Journal of Cardiovascular Pharmacology|November 22, 2007
Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrelChristopher D Payne, Ying Grace Li, David S Small, et al.Cytotherapy|November 5, 2025
Pilot study of early BK polyomavirus in the urine and risk of hemorrhagic cystitis after allogeneic hematopoietic cell transplantationYeon Joo Lee, Yuxuan Li, Michael Scordo, et al.Journal of Cardiovascular Pharmacology|January 27, 2011
The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology dataBaojin Zhu, Mark B Effron, M Pandurang Kulkarni, et al.Thrombosis and Haemostasis|December 11, 2012
Decrease in high on-treatment platelet reactivity (HPR) prevalence on switching from clopidogrel to prasugrel: insights from the switching anti-platelet (SWAP) studyJorge F Saucedo, Dominick J Angiolillo, Roger DeRaad, et al.Platelets|July 29, 2009
Inhibition of platelet aggregation with prasugrel and clopidogrel: an integrated analysis in 846 subjectsYing G Li, Lan Ni, John T Brandt, et al.Thrombosis Research|July 16, 2014
The influence of body size on the pharmacodynamic and pharmacokinetic response to clopidogrel and prasugrel: a retrospective analysis of the FEATHER studyJoseph A Jakubowski, Dominick J Angiolillo, Chunmei Zhou, et al.Pageof 50